Your browser doesn't support javascript.
loading
SEOM clinical guidelines in early stage breast cancer (2018)
Ayala de la Peña, F; Andrés, R; Garcia-Sáenz, JA; Manso, L; Margelí, M; Dalmau, E; Pernas, S; Prat, A; Servitja, S; Ciruelos, E.
Afiliação
  • Ayala de la Peña, F; Hospital General Universitario Morales Meseguer. Department of Hematology and Medical Oncology. Murcia. Spain
  • Andrés, R; Hospital Clínico Universitario Lozano Blesa. Division of Medical Oncology. Zaragoza. Spain
  • Garcia-Sáenz, JA; Hospital Clínico Universitario San Carlos. Department of Medical Oncology. Madrid. Spain
  • Manso, L; University Hospital 12 de Octubre. Department of Medical Oncology. Madrid. Spain
  • Margelí, M; Institut Català d'Oncologia. Department of Medical Oncology. Badalona Research Group of Oncology (B-ARGO Group). Breast Cancer Unit. Badalona. Spain
  • Dalmau, E; Parc Taulí Sabadell. Hospital Universitari. Department of Oncology. Sabadell. Spain
  • Pernas, S; Institut Català d'Oncologia. Department of Medical Oncology. Breast Cancer Unit. Barcelona. Spain
  • Prat, A; Hospital Clínic. Department of Medical Oncology. Barcelona. Spain
  • Servitja, S; Hospital del Mar. Department of Medical Oncology. Barcelona. Spain
  • Ciruelos, E; University Hospital 12 de Octubre. Department of Medical Oncology. Breast Cancer Unit. Madrid. Spain
Clin. transl. oncol. (Print) ; 21(1): 18-30, ene. 2019. tab
Article em En | IBECS | ID: ibc-183341
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy
RESUMEN
No disponible
Assuntos

Texto completo: 1 Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias da Mama / Quimioterapia Adjuvante / Carcinoma Ductal de Mama / Terapia Neoadjuvante / Carcinoma de Mama in situ Limite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias da Mama / Quimioterapia Adjuvante / Carcinoma Ductal de Mama / Terapia Neoadjuvante / Carcinoma de Mama in situ Limite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2019 Tipo de documento: Article